Patents by Inventor Lars Ynddal

Lars Ynddal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pancreatic Peptide Compounds and Use
    Publication number: 20150141336
    Abstract: The invention relates to novel use of Pancreatic Polypeptides as well as novel Pancreatic Polypeptides and compositions thereof. Such peptides can be used in treating or preventing conditions responsive to Y4 and/or Y5 receptor activation, such as cachexia.
    Type: Application
    Filed: May 17, 2013
    Publication date: May 21, 2015
    Inventors: Rasmus Joergensen, Soeren Oestergaard, Lars Ynddal, Flemming Seier Nielsen
  • LONG-ACTING Y2 RECEPTOR AGONISTS
    Publication number: 20130096055
    Abstract: The present invention relates to PYY derivatives comprising a serum albumin binding side chain, wherein said derivative has a half-life of at least 7 hours as determined by Assay (IV) described herein as well as compositions comprising said derivative and its use in therapy.
    Type: Application
    Filed: November 15, 2010
    Publication date: April 18, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Jacob Kofoed, Lars Ynddal, Soeren Oestergaard, Rasmus Joergensen, Flemming Sejer Nielsen, Cecilia Nilsson, Jens Kaalby Thomsen